AOD-9604 Peptide Therapy
AOD-9604 is a synthetic fragment of human growth hormone (residues 177-191). Researched for lipolytic (fat-breakdown) effects without the systemic GH side-effect profile.
/)
/)
What AOD-9604 may support
AOD-9604 was originally developed as an oral anti-obesity agent. Research has focused on its lipolytic action on stored fat and possible effects on cartilage and joint tissue, without GH-receptor downstream effects.
Our team evaluates suitability case-by-case, often as adjunct to a broader metabolic or weight-management plan rather than a stand-alone solution.
Patient experiences
Doctor was clear that AOD-9604 is an adjunct, not a magic pill. We built a 16-week plan with diet and training first, peptide second.
Specifically wanted something that wouldn't mess with my IGF-1. The mechanism matched what I needed.
Combined with a metabolic workup. The fat loss was modest but consistent over 12 weeks.
Our solutions for Weight‑Loss Management
What BPC-157 is studied for
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
/)
What is AOD-9604?
AOD-9604 is a synthetic fragment of human growth hormone (residues 177-191). Researched for lipolytic (fat-breakdown) effects without the systemic GH side-effect profile.
/)
How AOD-9604 may work
AOD-9604 is the 177 to 191 fragment of human growth hormone, retaining lipolytic action on adipose tissue but lacking the GH-receptor and IGF-1 effects of full HGH.
/)
Who it may be evaluated for
Adults working on resistant fat depots alongside diet and training, who want a metabolic adjunct without GH-receptor activation. Doctor reviews metabolic and hormone baseline.
/)
How Menscape prescribes AOD-9604
Daily subcutaneous injection over 12 to 16 weeks, paired with the patient's existing nutrition and training plan. Body-composition tracking at baseline and end.
Doctor-led evaluation
Every AOD-9604 protocol starts with a full medical consultation and history review.
Licensed compounding pharmacy
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Monthly monitoring
Follow-up consultations every four to six weeks to assess response and safety.
Research-informed positioning
We frame AOD-9604 as a research-stage peptide and prescribe only when clinically appropriate.
AOD-9604 questions
Is AOD-9604 the same as HGH?
No. AOD-9604 is a 15-amino-acid fragment of HGH. It retains the lipolytic action but lacks the growth-promoting and glucose-modulating effects of full HGH.
How is AOD-9604 dosed?
Subcutaneous injection, typically daily for 12 to 16 weeks. Doctor sets dose based on body composition goals.
Does AOD-9604 work without diet and training?
No. Like most metabolic peptides, AOD-9604 is an adjunct. Without aligned nutrition and movement, results are modest.
Is AOD-9604 FDA-approved?
No. AOD-9604 has been studied extensively but did not progress through full FDA approval. Use is off-label and doctor-supervised.
What measurements do you take before starting?
Baseline weight, waist circumference, body composition (DEXA or bioimpedance when available), fasting glucose, and lipid panel. We re-measure at the midpoint and end of the 12 to 16 week protocol.
When will I see changes?
Body-composition changes are typically gradual and most visible from week 8 onwards, alongside aligned nutrition and training. The clinic reviews progress at 4 to 6 week check-ins.
Talk with our medical team about BPC-157
/)